Apogee Therapeutics Inc
NASDAQ:APGE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apogee Therapeutics Inc
NASDAQ:APGE
|
US |
|
E
|
Elica SpA
F:7L4
|
IT |
|
Global Hemp Group Inc
F:GHG
|
CA |
|
E
|
Eco World International Bhd
KLSE:EWINT
|
MY |
|
PSP Swiss Property AG
OTC:PSPSF
|
CH |
|
Carbios SA
OTC:COOSF
|
FR |
|
B
|
Botanix Pharmaceuticals Ltd
OTC:BXPHF
|
AU |
|
O
|
Oxford Industries Inc
F:OXD
|
US |
|
Allreal Holding AG
F:AZ4N
|
CH |
|
City Holding Co
NASDAQ:CHCO
|
US |
|
Unicaja Banco SA
MAD:UNI
|
ES |
|
Smith & Nephew PLC
LSE:SN
|
UK |
|
Wingstop Inc
NASDAQ:WING
|
US |
|
F
|
FB Financial Corp
F:2J2
|
US |
|
W
|
Westinghouse Air Brake Technologies Corp
XBER:WB2
|
US |
|
O
|
Oppstar Bhd
KLSE:OPPSTAR
|
MY |
|
Cantor Equity Partners Inc
NASDAQ:CEP
|
US |
|
F
|
Franco-Nevada Corp
F:3FO
|
CA |
|
A
|
Arkema SA
XMUN:V1S
|
FR |
|
Victoria Care Indonesia Tbk PT
IDX:VICI
|
ID |
|
Silk Laser Australia Ltd
ASX:SLA
|
AU |
Wall St Price Targets
APGE Price Targets Summary
Apogee Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for APGE is 133.18 USD with a low forecast of 81.81 USD and a high forecast of 143.85 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is APGE's stock price target?
Price Target
133.18
USD
According to Wall Street analysts, the average 1-year price target for APGE is 133.18 USD with a low forecast of 81.81 USD and a high forecast of 143.85 USD.